Trials / Unknown
UnknownNCT03864588
Comparing Ropivacaine Adductor Canal Blockade by Surgeon Versus Anesthesiologist
A Randomized Controlled Trial Comparing Intraoperative Surgeon-Performed Versus Anesthesiologist-Performed Adductor Canal Blockade After Primary Total Knee Arthroplasty
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 164 (estimated)
- Sponsor
- Rothman Institute Orthopaedics · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of two methods of administering an adductor canal block (ACB) following total knee arthroplasty (TKA); intraoperative surgeon performed intra-articular adductor canal block (IACB) and anesthesiologist ultrasound guided ADC in the post-anesthesia recovery unit (PACU).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine | For primary TKA, Ropivacaine is used in both arms, either performed intra-operatively by surgeon or post-operatively (ultrasound guided) by anesthesiologist. |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2019-06-01
- Completion
- 2019-09-01
- First posted
- 2019-03-06
- Last updated
- 2019-03-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03864588. Inclusion in this directory is not an endorsement.